Drug Profile
Parainfluenza virus vaccine - Pharmacia
Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Pharmacia Corporation
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Parainfluenza virus infections
Most Recent Events
- 06 Apr 2000 Pharmacia & Upjohn has merged with Monsanto to form Pharmacia Corporation
- 27 Jul 1999 New profile, split from generic Parainfluenza virus vaccine profile
- 27 Jul 1999 Preclinical development for Parainfluenza virus infections in United Kingdom (Unknown route)